The increase in medication abortion comes as access to abortion in the U.S. has the potential to be dramatically altered this year.
77% of retail CFD accounts lose money.Plus500 stands during volatile times to offer the best possible trading experience under all market conditions.Even as the Omicron wave winds down, federal health officials, experts and the vaccine makers are already preparing for a potential fourth COVID shot to protect against whatever may come next. The catch: It's not yet clear whether another booster shot will be needed.
Driving the news: While cases and hospitalizations are plummeting worldwide after massive Omicron-fueled surges, the spread of an even more transmissible Omicron subvariant is making some experts nervous as states lift mask mandates and other restrictions.Stay on top of the latest market trends and economic insights with Axios Markets. Subscribe for free"The bottom line is we're relatively optimisVir has said the drug, sotrovimab, retains neutralizing activity against the emerging BA.